Brief: Eloxx Pharmaceuticals Granted Extension By Nasdaq To Regain Compliance

Eloxx Pharmaceuticals

03/08/2023 14:31

Aug 3 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS GRANTED EXTENSION BY NASDAQ TO
REGAIN
COMPLIANCE WITH THE MARKET VALUE OF LISTED SECURITIES CONTINUED
LISTING REQUIREMENT

Source text for Eikon:  ID:nGNXbS6Kj0 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))